Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Profit After Tax: 2024-2025

Historic Profit After Tax for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$22.0 million.

  • Pyxis Oncology's Profit After Tax fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.1 million, marking a year-over-year change of. This contributed to the annual value of -$77.3 million for FY2024, which is 4.78% down from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Profit After Tax is -$22.0 million, which was down 19.88% from -$18.4 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Profit After Tax peaked at -$3.3 million during Q1 2024, and registered a low of -$35.5 million during Q4 2024.
  • In the last 2 years, Pyxis Oncology's Profit After Tax had a median value of -$21.2 million in 2025 and averaged -$19.8 million.
  • Data for Pyxis Oncology's Profit After Tax shows a maximum YoY plummeted of 542.42% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Profit After Tax stood at -$35.5 million in 2024, then declined by 3.77% to -$22.0 million in 2025.
  • Its last three reported values are -$22.0 million in Q3 2025, -$18.4 million for Q2 2025, and -$21.2 million during Q1 2025.